Connection

Stephen Gardner to Hepacivirus

Back to Details
This is a "connection" page, showing publications Stephen Gardner has written about Hepacivirus.
Stephen Gardner
Connection Strength
0.432
Hepacivirus
  1. A double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-infected treatment-naive subjects. Liver Int. 2014 Jul; 34(6):e89-95.
    View in: PubMed
    Score: 0.432
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.